CNS Tumor

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

A Study of PHST001 in Advanced Solid Tumors

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer

Artificial Intelligence in CNS Radiation Oncology

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations

Effectiveness of Care in Certified Cancer Centres in Germany

Artificial Intelligence Neuropathologist

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma